Webinar Pre-Test: Female Sexual Health: Education, Diagnosis, and Treatment (2 of 3)

Pre-Test

Please take a minute to complete this pre-webinar survey to gauge your existing knowledge of the subject matter and to help ARHP assess the impact of our educational programs. Completing this survey will provide ARHP with valuable information for understanding how health care professionals use educational offerings and how ARHP activities might be improved to serve you better.

Question Title

* 1. Today's date (MM/DD/YYYY):

Question Title

* 2. How did you hear about this ARHP educational activity? (Please check all that apply.)

From an email from ARHP

From the ARHP website

From a colleague or friend

From social media (Facebook, Twitter, LinkedIn)

Other (please specify)

Question Title

* 3. Your primary professional category (choose the one best response):

Health Professional Educator

Nurse Midwife

Nurse Practitioner

Pharmacist

Physician

Physician Assistant

Registered Nurse

Resident

Student

Other (please specify)

Question Title

* 4. Do you interact with patients?

Yes

Question Title

* 5. Which of the following is NOT associated with adverse sexual side effects?

A. Bupropion

B. Selective serotonin reuptake inhibitors (SSRIs)

C. Histamine-receptor blockers

D. All of the above

E. None of the above

Question Title

* 6. Which of the following is a true statement about the evaluation of hypoactive sexual desire disorder (HSDD)

A. Serum testosterone should be measured in all patients with HSDD

B. Previous contraception history is a relevant aspect of the evaluation

C. A bimanual exam is always indicted

D. All of the above

E. None of the above

Question Title

* 7. Which is true about screening for female sexual dysfunctions?

A. Clinicians should wait until the woman reports a concern before conducting screening

B. It is best to begin with a closed-ended question before using an open-ended question

C.It is important to ask about problems with sexual desire

D. All of the above

E. None of the above

Question Title

* 8. Which of the following is true about the general approach to the treatment of hypoactive sexual desire disorder (HSDD)

A. Patient and partner education is an essential component of treatment

B. Treatment of contributing medical conditions is an important first step

C. Substance use should be considered as potentially playing a causative role

D. All of the above

E. None of the above

Question Title

* 9. As a result of participating in this activity, I hope to be better able to:

Thank you for completing this pre-session questionnaire. Please see the reminder e-mail for complete instructions on how to access the webinar. If you have any questions, please contact education@arhp.org.